Propel Drug-Eluting Sinus Stent Family Open Cohort

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

February 19, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Rhinosinusitis (Diagnosis)
Interventions
OTHER

NA-Observational Registry

NA Observational Registry

Trial Locations (9)

Unknown

Saint Elisabeth Krankenhaus Köln-Hohenlind, Cologne

Universitätsklinikum Freiburg Klinik für Hals, Nasen und Ohrenheilkunde, Freiburg im Breisgau

Katholisches Krankenhaus Hagen, Hagen

Städtisches Klinikum Karlsruhe GmbH, Karlsruhe

Universitätsklinikum Schleswig-Holstein Campus Lübeck, Lübeck

HNO Praxis & Rhinologie Zentrum München, München

Universitätsklinikum Münster Klinik für Hals, Nasen und Ohrenheilkunde, Münster

Helios Dr Horst Schmidt Kliniken, Wiesbaden

Imperial College Healthcare NHS Trust - Charing Cross Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic

INDUSTRY

NCT05925985 - Propel Drug-Eluting Sinus Stent Family Open Cohort | Biotech Hunter | Biotech Hunter